Eris Lifesciences stated that its consolidated net profit increased 12 per cent to Rs 101 crore for the third quarter ended December 2021.
The company stated that the revenue stood at Rs 332 crore in the third quarter of the current fiscal as against Rs 310 crore in the year-ago period, Eris Lifesciences said.
''Our focus on building leadership brands in fast-growing therapies coupled with several patent expiration opportunities will enable us to sustain our growth trajectory,'' stated Eris Lifesciences Chairman & Managing Director Amit Bakshi.
(With inputs from PTI)
Mumbai Weather Update: Pleasant Morning At 23 Degrees But AQI Remains Unhealthy
Big Update On BMC Elections 2025/26: Poll Dates Likely To Be Announced On Monday As Political Buzz Intensifies
Mumbai College Dress Code Controversy: Burqa, Hijab And Students’ Right To Education
GOAT India Tour: Viral Video Claims Translator Called Rahul Gandhi 'PM' During Lionel Messi's Speech In Hyderabad
